The global Bovine Mastitis Market size was valued at USD 540 million in 2021 and is projected to reach around USD 1,100 million in 2030 exhibiting a CAGR of 6.5% in the forecasted period. The report covers all information about the global and regional markets, including historical and future trends for market dominance, size, trades, supply, competitors, and prices, as well as key vendor information across the globe. Forecast market information, SWOT analysis, Bovine Mastitis market scenario, and feasibility study are important aspects in this report.
The development of the bovine mastitis market and the introduction of new products are driving factors contributing to the manufacturers' and developers' increased interest in the disease. For example, Ecolab Inc., the world leader in water, food safety, and health technologies and services, unveiled Eco-Flex Teat Dip in February 2022. It is an economical and efficient udder care product for dairy cows that supports milk quality, helps avoid infection, and enhances teat health. The market is growing as a result of manufacturers working together to establish a presence in emerging markets. Furthermore, the market is anticipated to develop as a result of rising government initiatives to provide healthcare services for animals as well as increased demand for dairy products.
Get a sample copy of this report: https://wemarketresearch.com/reports/request-free-sample-pdf/bovine-mastitis-market/859
Companies Covered: Bovine Mastitis Market:
Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Bayer AG
• Elanco
• Ceva
• West Way Health
• Norbrook
• DeLaval
• ImmuCell Corporation
• Advanced Animal Diagnostics
• Nimrod Veterinary Products Ltd.
• Other players
These companies have the potential to drive market growth through various strategies. They can focus on offering innovative and high-performance products, taking advantage of advancements in technology. Additionally, expanding their distribution channels to target new customers would be beneficial. Strategic partnerships and collaborations can also be pursued to strengthen market presence and enhance competitiveness.
Global Bovine Mastitis Market Segmentation:
By Type
• Clinical Mastitis
• Sub-clinical Mastitis
By Product
• Antibiotics
• Vaccines
• Pain Killers
• Others
By Route of Administration
• Intra-mammary
• Systemic
By Therapy
• Lactating Period
• Dry Period
o Antibiotics
o Teat Sealants
By End User
• Veterinary Centers
• Hospital
• Clinics
• Others
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt
Bovine Mastitis Sector: Growth Drivers and Challenges:
Growth Drivers:
Enormous Surge in Dairy Production Across the Globe - Dairy farming, usually referred to as dairying, is closely related to dairy production. Breeding, raising, and using dairy animals mainly cows for the purpose of producing milk and the many dairy products derived from them is the scope of this agricultural specialty. From now on, the rise in dairy products has a significant effect on the health and cleanliness of cows, driving the market's expansion during the projected time. For example, global milk production in 2020 was close to 907 million tons, up 3% from 2019.
Worldwide Rise in the Number of Farm Cattle - For example, it was projected that the number of cattle worldwide would be approximately 1.5 billion in 2022—a marginal increase from 998 million in 2021.
Globally Escalating Consumption of Milk- For example, in 2021, India consumed around 85 million metric tons of cow milk, making it the world's largest consumer. In contrast, the European Union used 24 million metric tons of milk, the most of any country.
Rising Count of Veterinary Hospitals and Polyclinics:
For example, in India, there were over 12,070 veterinary hospitals and polyclinics in the fiscal year 2021. In addition, there were over 67,000 veterinary clinics and a large number of assistance centers and pharmacies in the nation that year.
Global Rise in Research and Development Investment: As per the report of the UNESCO Institute for Statistics, with an average annual growth rate of 4.7% over the past ten years, global R&D investment has risen significantly from 2010-2020. Globally, from 1.61% in 2010 to 1.93% in 2020, the percentage of global GDP invested in research and development has increased exponentially.
Challenges:
Increase in Antibiotic Resistance Pathogen - The prolonged use of antibiotics to treat Bovine Mastitis led to a surge in antimicrobial resistance in the pathogens that cause this infectious disease in cattle. Subsequently, the increase in multi-resistant strains reduces the effectiveness of the antibiotics that are associated with the treatment. Thus, this factor is estimated to hamper the market’s growth during the forecast period.
Directly Purchase a Copy of this Bovine Mastitis Market research report at: https://wemarketresearch.com/purchase/bovine-mastitis-market/859?license=single
The research includes historical data from 2018 to 2023 and forecasts until 2033, making the report valuable to industry executives, marketing, sales and product managers, consultants, analysts, and stakeholders in clearly presented tables Together, we are looking for documents that are easily accessible graph.
Related Reports
Chronic Gingivostomatitis Treatment Market
Asia Pacific Pain Management Therapeutics Market
About We Market Research:
WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.
Contact Us:
Mr. Robbin Joseph
Corporate Sales, USA
We Market Research
USA: +1-724-618-3925
Websites: https://wemarketresearch.com/
Email: [email protected]